Two vitamin listed companies release results for Q3 2024

On 18 Oct., Zhejiang Garden Biopharmaceutical Co., Ltd. (Garden Biopharmaceutical) disclosed results for Q3 2024. Q3 2024Revenue: USD47.72 million (RMB337.42 million), increased of 39.99% YoYNet profit attributable to shareholders: USD14.05 million (...

Vitamins China E-News 202410

www.cnchemicals.com